CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s. [electronic resource]
Producer: 20200120Description: 2929-2942 p. digitalISSN:- 1097-4652
- Animals
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Disease Progression
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Heterografts
- Humans
- Mice
- PAX2 Transcription Factor -- genetics
- Pyrimidines -- pharmacology
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.